SCHEMBL5778726

SCHEMBL5778726

O=C(O)c1cnc(Cl)cc1-c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.46
DHODH Q02127 2/20 0.45
EIF4E P06730 2/20 0.43
KDM4E B2RXH2 3/20 0.43
BRS3 P32247 1/20 0.42
DDT P30046 1/20 0.41
XDH P47989 2/20 0.41
SLC22A12 Q96S37 1/20 0.41
GPR35 Q9HC97 2/20 0.41
BCL2L1 Q07817 1/20 0.41
BAD Q92934 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
DHFR P00374 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
TTR P02766 1/20 0.40
ALB P02768 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27541520 0.85 DDT (0.51) DHODHDDTALDH1A1MEN1HPGD
SCHEMBL29186263 0.81 NAPRT (0.45) KDM4EDDTALDH1A1CA1CA2
SCHEMBL31392226 0.81 DDT (0.39) MAP4K4DHODHKDM4EBRS3DDT
SCHEMBL5783181 0.81 GPBAR1 (0.53) DHODHKDM4EALDH1A1MEN1USP2
SCHEMBL16635354 0.80 MAP4K4 (0.42) MAP4K4
SCHEMBL7114202 0.79 LMNA (0.50) ALDH1A1LMNAMAPTSMN1; SMN2KCNQ3
SCHEMBL17797021 0.78 HSD17B10 (0.51) MAP4K4DHODHKDM4EGPR35BCL2L1
SCHEMBL31676805 0.78 HSD17B10 (0.51) MAP4K4DHODHKDM4EGPR35BCL2L1
SCHEMBL21938180 0.77 BCL2L1 (0.54) MAP4K4DHODHEIF4EKDM4EGPR35
SCHEMBL30919866 0.76 RPS6KA3 (0.44) MAP4K4KDM4EALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1293056-C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists HOFFMANN LA ROCHE (CH) 2007-01-03 CN disclosed
EP-1309559-B1 4-PHENYL-PYRIDINE DERIVATIVES AS NEUROKININ-1 RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2006-06-07 EP disclosed
CN-1610670-A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists HOFFMANN LA ROCHE (CH) 2005-04-27 CN disclosed
US-6770637-B2 N-(3,5-BIS-TRIFLUOROMETHYL-BENZYL)-6-(4-HYDROXYACETYL-PIPERAZIN-1 -YL)-N-METHYL-4-O-TOLYL-NICOTINAMIDE, FOR EXAMPLE HOFFMANN-LA ROCHE INC. 2004-08-03 US disclosed
EP-1309559-A1 4-PHENYL-PYRIDINE DERIVATIVES AS NEUROKININ-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-05-14 EP disclosed
US-20020040040-A1 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors F. HOFFMAN-LA ROCHE AG (CH) 2002-04-04 US disclosed
WO-2002016324-A1 4-PHENYL-PYRIDINE DERIVATIVES AS NEUROKININ-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020040040-A1 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors NPSR1, NTSR1, NTSR2 MAP4K4 327/4885DHODH 3879/4885EIF4E 3984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.